<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Trotta MC</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Diabetic tendinopathy is a common invalidating and challenging disease that may be treated using stem cells. However, the effects of adipose-derived mesenchymal stem cell conditioned medium (ASC-CM) in diabetic tendinopathy have never been explored.&lt;h4>Objectives&lt;/h4>The present study evaluated the effects of ASC-CM on morphology, cell viability, structure, and scratch wound closure of human tenocytes (HTNC) exposed to high glucose (HG).&lt;h4>Design&lt;/h4>Experimental study.&lt;h4>Methods&lt;/h4>HTNC were exposed to HG (25 mM) for 7, 14 and 21 days with or without ASC-CM for the last 24 h. CM was collected from 4 × 10&lt;sup>5&lt;/sup> ASCs, centrifuged for 10 min at 200 g and sterilized with 0.22 μm syringe filter.&lt;h4>Results&lt;/h4>At 7 days, HG-HTNC had decreased cell viability [72 ± 2%, &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> normal glucose (NG)] compared to NG-HTNC (90 ± 5%). A further decrement was detected after 14 and 21 days (60 ± 4% and 60 ± 5%, both, &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> NG and &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> HG7). While NG-HTNC evidenced a normal fibroblast cell-like elongated morphology, HG-HTNC showed increased cell roundness. In contrast, HG-HTNC exposed to ASC-CM showed a significant increase in cell viability, an improved cell morphology and higher scratch wound closure at all HG time points. Moreover, the exposure to ASC-CM significantly increased thrombospondin 1 and transforming growth factor beta 1 (TGF-β1) content in HG-HTNC. The TGF-β1 elevation was paralleled by higher Collagen I and Vascular Endothelial Growth Factor in HG-HTNC.&lt;h4>Conclusion&lt;/h4>ASC-CM may restore the natural morphology, cell viability and structure of HTNC, promoting their scratch wound closure through TGF-β1 increase.</pubmed_abstract><journal>Therapeutic advances in musculoskeletal disease</journal><pagination>1759720X231214903</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10775729</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose.</pubmed_title><pmcid>PMC10775729</pmcid><pubmed_authors>Itro A</pubmed_authors><pubmed_authors>Lepre CC</pubmed_authors><pubmed_authors>Moretti A</pubmed_authors><pubmed_authors>D'Amico M</pubmed_authors><pubmed_authors>Braile A</pubmed_authors><pubmed_authors>Toro G</pubmed_authors><pubmed_authors>Trotta MC</pubmed_authors><pubmed_authors>Russo M</pubmed_authors><pubmed_authors>Guida F</pubmed_authors><pubmed_authors>Tarantino U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose.</name><description>&lt;h4>Introduction&lt;/h4>Diabetic tendinopathy is a common invalidating and challenging disease that may be treated using stem cells. However, the effects of adipose-derived mesenchymal stem cell conditioned medium (ASC-CM) in diabetic tendinopathy have never been explored.&lt;h4>Objectives&lt;/h4>The present study evaluated the effects of ASC-CM on morphology, cell viability, structure, and scratch wound closure of human tenocytes (HTNC) exposed to high glucose (HG).&lt;h4>Design&lt;/h4>Experimental study.&lt;h4>Methods&lt;/h4>HTNC were exposed to HG (25 mM) for 7, 14 and 21 days with or without ASC-CM for the last 24 h. CM was collected from 4 × 10&lt;sup>5&lt;/sup> ASCs, centrifuged for 10 min at 200 g and sterilized with 0.22 μm syringe filter.&lt;h4>Results&lt;/h4>At 7 days, HG-HTNC had decreased cell viability [72 ± 2%, &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> normal glucose (NG)] compared to NG-HTNC (90 ± 5%). A further decrement was detected after 14 and 21 days (60 ± 4% and 60 ± 5%, both, &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> NG and &lt;i>p&lt;/i> &lt; 0.01 &lt;i>versus&lt;/i> HG7). While NG-HTNC evidenced a normal fibroblast cell-like elongated morphology, HG-HTNC showed increased cell roundness. In contrast, HG-HTNC exposed to ASC-CM showed a significant increase in cell viability, an improved cell morphology and higher scratch wound closure at all HG time points. Moreover, the exposure to ASC-CM significantly increased thrombospondin 1 and transforming growth factor beta 1 (TGF-β1) content in HG-HTNC. The TGF-β1 elevation was paralleled by higher Collagen I and Vascular Endothelial Growth Factor in HG-HTNC.&lt;h4>Conclusion&lt;/h4>ASC-CM may restore the natural morphology, cell viability and structure of HTNC, promoting their scratch wound closure through TGF-β1 increase.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-04T13:58:19.944Z</modification><creation>2025-04-04T13:58:19.944Z</creation></dates><accession>S-EPMC10775729</accession><cross_references><pubmed>38204801</pubmed><doi>10.1177/1759720X231214903</doi></cross_references></HashMap>